Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2015 Feb 11;15(7):420–427. doi: 10.1016/j.clml.2015.02.001

Figure 1.

Figure 1

Time-to-first-treatment (TTT). A. The median TTT was significantly shorter for patients with +12 than for patients with negative FISH (38 vs 82 months, p<0.001). B. On MVA, CBA positivity for del(14q) was associated with a significantly shorter TTT (11 vs 37 months, p=0.001).